T R Kozel - JoVE Visualize

Showing results (71-80 of 81) with videos related to

Pageof 9

Sort By:

Infection and Immunity|April 7, 1998

Characterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Cryptococcus neoformans capsuleT R Kozel, B C deJong, M M Grinsell, et al.

Infection and Immunity|February 1, 1988

Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigensJ W Murphy, R L Mosley, R Cherniak, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2001

Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasisY Han, T R Kozel, M X Zhang, et al.

Infection and Immunity|March 1, 1997

Binding of Cryptococcus neoformans to heterologously expressed human complement receptorsS M Levitz, A Tabuni, T R Kozel, et al.

Infection and Immunity|November 1, 1995

Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsuleA S Ibrahim, S G Filler, M S Alcouloumre, et al.

Infection and Immunity|May 1, 1997

Structure and biological activities of acapsular Cryptococcus neoformans 602 complemented with the CAP64 geneY C Chang, R Cherniak, T R Kozel, et al.

Infection and Immunity|October 24, 2012

A purified capsular polysaccharide markedly inhibits inflammatory response during endotoxic shockM Piccioni, C Monari, S Kenno, et al.

Infection and Immunity|May 1, 1997

Acute lethal toxicity following passive immunization for treatment of murine cryptococcosisA C Savoy, D M Lupan, P B Manalo, et al.

Medical Mycology|January 19, 2002

An immunohistochemical method that differentiates Cryptococcus neoformans varieties and serotypes in formalin-fixed paraffin-embedded tissuesM B Krockenberger, P J Canfield, T R Kozel, et al.

Antimicrobial Agents and Chemotherapy|June 13, 1998

Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studiesA Casadevall, W Cleare, M Feldmesser, et al.

Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:

Pageof 9

Infection and Immunity|April 7, 1998

Characterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Cryptococcus neoformans capsuleT R Kozel, B C deJong, M M Grinsell, et al.

Infection and Immunity|February 1, 1988

Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigensJ W Murphy, R L Mosley, R Cherniak, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2001

Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasisY Han, T R Kozel, M X Zhang, et al.

Infection and Immunity|March 1, 1997

Binding of Cryptococcus neoformans to heterologously expressed human complement receptorsS M Levitz, A Tabuni, T R Kozel, et al.

Infection and Immunity|November 1, 1995

Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsuleA S Ibrahim, S G Filler, M S Alcouloumre, et al.

Infection and Immunity|May 1, 1997

Structure and biological activities of acapsular Cryptococcus neoformans 602 complemented with the CAP64 geneY C Chang, R Cherniak, T R Kozel, et al.

Infection and Immunity|October 24, 2012

A purified capsular polysaccharide markedly inhibits inflammatory response during endotoxic shockM Piccioni, C Monari, S Kenno, et al.

Infection and Immunity|May 1, 1997

Acute lethal toxicity following passive immunization for treatment of murine cryptococcosisA C Savoy, D M Lupan, P B Manalo, et al.

Medical Mycology|January 19, 2002

An immunohistochemical method that differentiates Cryptococcus neoformans varieties and serotypes in formalin-fixed paraffin-embedded tissuesM B Krockenberger, P J Canfield, T R Kozel, et al.

Antimicrobial Agents and Chemotherapy|June 13, 1998

Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studiesA Casadevall, W Cleare, M Feldmesser, et al.

Pageof 9